28 Sep 2026 Botox Meets Hernia Surgery

You may know Botox from the world of cosmetics, but it has found a powerful role in the repair of complex hernia. Before surgery, a simple injection can relax the abdominal muscles temporarly, giving surgeons a better chance to repair large hernias without tension, and giving to the patients a better chance of lasting results.

What is Botox?

Botox is actually the trade name of the drug. It is a brand of the company Allergan. It contains Botulinum Toxin A (BTA), a neurotoxin obtained from the bacterium Clostridium Botulinum. It acts on nerve endings and blocks them. It is widely used in the treatment of migraine, muscle spasms, excessive sweating, and in aesthetic procedures. In recent years, it has also found a place in the treatment of large abdominal wall and incisional hernias.

Basic facts about incisional hernias

Incisional hernias occur most often at the midline. In hernia repair, the vertical (longitudinal) size of the defect is not as important as its transverse (horizontal) width. Through retromuscular dissection, the plane can be extended upward to the xiphoid bone and the central tendon of the diaphragm, and downward to the pubic bone and further to Cooper’s ligament, allowing adequate mesh overlap in the vertical direction; however, there are limitations to how far the dissection can extend transversely. In the onlay technique — placing the mesh in front of the abdominal wall muscles — wide skin and subcutaneous flaps are required, which often lead to wound problems such as seroma, infection, and skin necrosis. Furthermore, because there is no strong tissue layer in front of the mesh, it offers less resistance to intra-abdominal pressure. The retromuscular plane is the most suitable location for mesh placement, since it has muscle in front of it and integrates better with the surrounding tissue. Even here, however, there are limits: the lateral border of this plane is the outer edge of the rectus muscle, because the neurovascular structures supplying the muscle enter it at this point, and dissection cannot safely continue beyond this border. In large hernias, repair can remain weak both because of tension and because the mesh cannot be adequately extended laterally.

The Carbonell ratio

According to the ratio proposed by Dr. Alfredo Carbonell, a past president of the American Hernia Society: if twice the width of the hernia defect is smaller than the combined width of both rectus muscles, retrorectus repair is sufficient. If it exceeds this, a component separation technique is required — either Ramirez’s anterior component separation technique or Novitsky’s TAR (transversus abdominis release) technique.

The combined width of the two rectus muscles varies on average between 8 and 18 cm. Based on this, it can roughly be said that hernias up to 7–8 cm can be adequately repaired with the retrorectus repair aka Rives-Stoppa technique. Beyond this limit, achieving sufficient mesh overlap and closing the defect primarily becomes difficult; excessive tension develops along the suture line and the risk of dehiscence increases. Today, the common solution is component separation techniques; Botox has now begun, to a certain degree, to compete with these.

The anisotropic abdominal wall

The abdominal wall is anisotropic — that is, its degree of stretch differs by direction. It stretches by roughly 25% in the vertical plane and about 15% in the horizontal plane. That means abdominal wall is more flexible in vertical direction. For this reason, quality meshes are also manufactured to be anisotropic. In abdominal wall hernias, transverse forces — generated by the three lateral muscles: the external oblique (EO), internal oblique (IO), and transversus abdominis (TA) — place more strain on the repair than vertical forces do and are the an important determinant of recurrence.

Botox works!

If the medial pull exerted by this trio of lateral muscles is overcome, a large hernia defect can be closed without tension, and the rectus muscles can be returned to their original medial position, restoring a more physiological and functional abdominal wall. There are two ways to achieve this: component separation techniques — dividing the EO fascia longitudinally in the Ramirez technique, or releasing the medial attachment of the TA muscle in the TAR technique — or using Botox to temporarily paralyze and relax this muscle group, reducing tension on the repair. This is referred to as “chemical component separation.”

Botox reaches its maximum effect 4–6 weeks after injection, after which its effect gradually diminishes, disappearing almost completely by 4–6 months. This window is critical for fascial healing, and with the help of Botox, the fascia gains time to heal without tension. During this period, the abdominal wall is able to adapt.

In large anterior abdominal wall hernias, intra-abdominal organs migrate out of the abdominal cavity into the hernia sac and gradually enlarge the defect over time. As fewer organs remain within the abdomen, the abdominal cavity loses volume and shrinks. Eventually, this can reach a point where, at the time of repair, the herniated organs can no longer be returned to the abdominal cavity without creating tension. This is both a dangerous situation and a cause of early or late hernia recurrence due to tension. It can be estimated preoperatively with computed tomography using the Tanaka index: if the volume of the hernia sac exceeds 25% of the abdominal cavity volume, this is referred to as ‘loss of domain,’ and in these patients advanced component separation techniques, together with Botox and/or progressive pneumoperitoneum (PPP), may be required. Botox also produces a limited increase in intra-abdominal volume, of up to about 8%.

Component separation techniques are invasive, closing one side of the abdominal wall by mobilizing tissue from elsewhere; if not performed correctly, this can result in weakness and new, difficult hernias in previously healthy areas. Botox can reduce the size of the hernia defect, allowing the repair to be downgraded to a simpler technique — for example, a 10 cm hernia that might otherwise require component separation may instead be adequately repaired with Botox-assisted Rives-Stoppa. This naturally has a threshold: in giant hernias, Botox alone is not sufficient, though it can still assist component separation. Very roughly, it can be considered suitable for hernias in the 6–12 cm range; at the upper end of this range, the width of both rectus muscles must always be taken into account. A recent publication reported that hernia defects of 12–17 cm could be closed with Botox assistance and the repair downgraded to the Rives-Stoppa technique; however, insufficient mesh overlap may be a concern here, and the long-term follow-up results of this study are still awaited.

The standard use of Botox in incisional hernias is for defects wider than 10 cm. In selected cases, its use is becoming more widespread for hernias in the 5–10 cm range as well, to reduce the complexity of the repair. Because it is easy to administer and carries a low risk of serious side effects, its use — and its range of indications — continues to expand. Please read my blog post on ‘Downsizing the hernia repair in complex incisional hernia’ to gain broader knowledge on this topic

How is Botox administered?

Botox is administered 4–6 weeks before surgery. It can be safely given in an outpatient setting. After being diluted to a specific concentration, it is injected under ultrasound guidance into the three lateral muscles on both sides. No serious side effects have been reported.

Botox relieves pain!

Because Botox’s mechanism of action also blocks sensory nerves, patients who receive it tend to experience less postoperative pain.

In conclusion, the use of Botox in abdominal wall hernias offers significant benefits, and its range of applications continues to expand. It makes an important contribution to the success of hernia repair.